http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Yousef Moradi ),( Rozhin Khateri ),( Ladan Haghighi ),( Shoaib Dehghani ),( Shiva Mansouri Hanis ),( Mehrdad Valipour ),( Zahra Najmi ),( Zahra Fathollahy ),( Meisam Allahmoradi ),( Kamyar Mansori ) 대한산부인과학회 2020 Obstetrics & Gynecology Science Vol.63 No.4
Objective The aim of this systematic review and meta-analysis study was to determine the pooled estimate of the effect of antenatal magnesium sulfate (MgSO<sub>4</sub>) on intraventricular hemorrhage (IVH) in premature infants. Methods Two review authors independently searched all randomized clinical trials from international databases, including Medline (PubMed), Web of Sciences, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), and Research Registers of ongoing trials (ClinicalTrials.gov), from January 1989 to August 2017. Two independent review authors were responsible for data collection. After extracting the necessary information from the evaluated articles, metaanalysis of the data was performed using Stata version 14. Also, sources of heterogeneity among studies were determined by Meta regression. Results In this study, among 126 articles that were extracted from primary studies, 7 papers that evaluated the effect of MgSO<sub>4</sub> on IVH were eligible for inclusion in the meta-analysis. The results of the meta-analysis showed that pooled relative risk (95% confidence interval [CI]) was 0.80 (95% CI, 0.63 to 1.03) for the effect of MgSO<sub>4</sub> on IVH. Conclusion Results of this study showed that although MgSO<sub>4</sub> had a protective effect on IVH in premature infants, this effect was not statistically significant. Further studies are needed to determine the best dosage, timing, and gestational age to achieve the optimum effect of MgSO<sub>4</sub> on IVH.